Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Good afternoon ONC management

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Nov 13, 2023 2:18pm

189 Views

Post# 35732508

RE:RE:Good afternoon ONC management

Did I send this to Onc?
Not exactly, to protect my privacy & confidently of Onc.
I sent an email. With enough identification to know who I am.
Also,I have a long two way communication history going back to Michael Moore days.
Dr Matt knows of me.
In that regard, i will not discuss any correspondence either confirm or deny, receiving calls or not.
My interests are in the long term of Onc , shareholders & Pelarerrp
Great day all.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features